Crosstalk between ER stress and p53 pathway
ER 应激与 p53 通路之间的串扰
基本信息
- 批准号:16390290
- 负责人:
- 金额:$ 8.13万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Synoviolin is an E3 ubiquitin ligase and is implicated in endoplasmic reticulum-associated degradation. In mammals, Synoviolin plays crucial roles in various physiological and pathological processes, including embryogenesis and the pathogenesis of arthropathy. However, little is known about the molecular mechanisms of Synoviolin in these actions. To clarify these issues, we analyzed the profile of protein expression in synoviolin-null cells. Hereby, we found that Synoviolin targets tumor suppressor gene p53 for ubiquitination. Synoviolin sequestrated and metabolized p53 in the cytoplasm and negatively regulated its cellular level and biological functions, including transcription, cell cycle regulation and apoptosis. Furthermore, these p53 regulatory functions of Synoviolin were irrelevant to other E3 ubiquitin ligases for p53, such as MDM2, Pirh2 and Cop1, which form autoregulatory feedback loops. Our results provide novel insights into p53 signaling mediated by Synoviolin.
滑膜蛋白是一种E3泛素连接酶,参与内质网相关降解。在哺乳动物中,滑膜小提琴在各种生理和病理过程中起着至关重要的作用,包括胚胎发育和关节病的发病机制。然而,人们对Synoviolin在这些作用中的分子机制知之甚少。为了澄清这些问题,我们分析了滑膜素无效细胞中的蛋白质表达谱。因此,我们发现滑膜蛋白靶向肿瘤抑制基因p53的泛素化。滑膜素在细胞质中螯合和代谢p53,并负调节其细胞水平和生物学功能,包括转录、细胞周期调节和凋亡。此外,这些p53的调节功能的滑膜蛋白是无关的其他E3泛素连接酶的p53,如MDM 2,Pirh 2和Cop1,形成自动调节反馈回路。我们的研究结果提供了新的见解p53信号介导的Synoviolin。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The nuclear import of RNA helicase A is mediated by importin-α3
- DOI:10.1016/j.bbrc.2005.11.161
- 发表时间:2006-02
- 期刊:
- 影响因子:3.1
- 作者:S. Aratani;T. Oishi;Hidetoshi Fujita;M. Nakazawa;R. Fujii;N. Imamoto;Y. Yoneda;A. Fukamizu;
- 通讯作者:S. Aratani;T. Oishi;Hidetoshi Fujita;M. Nakazawa;R. Fujii;N. Imamoto;Y. Yoneda;A. Fukamizu;
The Nuclear Import of RNA helicase A is mediated by importin a3
RNA 解旋酶 A 的核输入由输入 a3 介导
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Satoko Aratani;et al.
- 通讯作者:et al.
Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'
- DOI:10.1038/sj.emboj.7601490
- 发表时间:2007-01-10
- 期刊:
- 影响因子:11.4
- 作者:Yamasaki, Satoshi;Yagishita, Naoko;Nakajima, Toshihiro
- 通讯作者:Nakajima, Toshihiro
Relevance of nuclear localization and functions of RNA helicase A.
- DOI:10.3892/ijmm.15.4.555
- 发表时间:2005-04
- 期刊:
- 影响因子:5.4
- 作者:Hidetoshi Fujita;T. Ohshima;T. Oishi;S. Aratani;R. Fujii;A. Fukamizu;T. Nakajima
- 通讯作者:Hidetoshi Fujita;T. Ohshima;T. Oishi;S. Aratani;R. Fujii;A. Fukamizu;T. Nakajima
Comparative Analysis of Gene Expression Profiles in Intact Versus Damaged Regions of Human Osteoarthritic Cartilage
人类骨关节炎软骨完整区域与受损区域基因表达谱的比较分析
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Tomoo Sato;et al.
- 通讯作者:et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKAJIMA Toshihiro其他文献
NAKAJIMA Toshihiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKAJIMA Toshihiro', 18)}}的其他基金
Molecularbasis of fibrosis by ERAD CER associated protein degradation.
ERAD CER 相关蛋白质降解导致纤维化的分子基础。
- 批准号:
23659176 - 财政年份:2011
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Integrated study on implication of Synoviolin in multiprocesses of rheumatoid arthritis.
滑膜素在类风湿关节炎多过程中的综合研究。
- 批准号:
20249052 - 财政年份:2008
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Molecular mechanism of transactivation via transcriptional coactivator complexes
通过转录共激活因子复合物反式激活的分子机制
- 批准号:
12480206 - 财政年份:2000
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Implication of transcriptional coactivator complexes in rheumatoid synovial cells
转录共激活复合物在类风湿滑膜细胞中的意义
- 批准号:
12557045 - 财政年份:2000
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Basis of Coactivator Function of RNA helicase A.
RNA 解旋酶 A 共激活子功能的分子基础。
- 批准号:
10480196 - 财政年份:1998
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 8.13万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 8.13万 - 项目类别:
Research Grant
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 8.13万 - 项目类别:
Operating Grants
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 8.13万 - 项目类别:
Fellowship
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 8.13万 - 项目类别:
Fibroblast-mediated inflammatory resolution of rheumatoid arthritis
成纤维细胞介导的类风湿性关节炎炎症消退
- 批准号:
10604629 - 财政年份:2023
- 资助金额:
$ 8.13万 - 项目类别:
A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis
一种有效的 TNFα D 肽抑制剂,用于治疗类风湿性关节炎
- 批准号:
10822182 - 财政年份:2023
- 资助金额:
$ 8.13万 - 项目类别:
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
- 批准号:
10733789 - 财政年份:2023
- 资助金额:
$ 8.13万 - 项目类别:
Microbial metabolites impacting the response to methotrexate in rheumatoid arthritis
微生物代谢物影响类风湿性关节炎对甲氨蝶呤的反应
- 批准号:
10578433 - 财政年份:2023
- 资助金额:
$ 8.13万 - 项目类别: